Treatment Registry
TR-0223 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Arc-1 · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$149

Medication · Product page starting price$149

Added from the figures recorded below.

Price

TermPer monthCharged today
Collection page listing

Compounded Tirzepatide Regular price From $199.99 Sale price From $199.99

source

Per month$199.99Charged today$199.99
Product page starting price

Delivered to you. No insurance required. Starting at $149/month

source

Per month$149Charged today$149
Visit Arc-1

We earn nothing from this link. Arc-1 has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberAsynchronous review

Not yet checked: pharmacy, states, cancellation, membership and consult fee.

Recorded from arc-1.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Two contradictions worth flagging: (1) the homepage collection grid prices tirzepatide the same as semaglutide ('From $199.99'), but the tirzepatide product detail page itself advertises 'Starting at $149/month' -- the two on-site prices for the same product disagree. (2) The state-exclusion list differs by product page: semaglutide excludes 'Arkansas, Indiana, Minnesota, Puerto Rico, or South Carolina' while tirzepatide excludes 'California, Arkansas, Indiana, Minnesota, or South Carolina' (California in one list, Puerto Rico in the other, not both). (3) Every dose variant on both product pages is marked 'Variant sold out or unavailable' at the moment fetched, so the advertised prices may not currently resolve to a purchasable product. Only a 30-day return policy on delivered goods was found; no subscription-cancellation policy was found.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0223
Readings
1

Related records

What else Arc-1 sells

All Arc-1 programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Arc-1 compounded tirzepatide (TR-0223). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0223

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.